Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Cholestenone
Cat. No.:
0225LY-1397
Appearance:
Solid
Purity:
≥97%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Cholestenone is an intermediate produced during cholesterol oxidation in the liver; it is highly mobile in cell membranes and can influence cholesterol turnover.
Synonym:
(+)-4-Cholesten-3-one; 601-57-0; 4-Cholesten-3-one; Cholest-4-en-3-one; 3-Oxocholest-4-ene; 3-Oxo-4-cholestene; Delta(sup 4)-Cholestenone; 3-Keto-4-cholestene; Cholestenone (delta 4); .Delta.4-Cholesten-3-one; 4-Cholestenone; (8alpha,9beta)-Cholest-4-En-3-One; (8S,9S,10R,13R,14S,17R)-10,13-Dimethyl-17-((R)-6-methylheptan-2-yl)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one
CAS No.:
601-57-0
Compound CID:
91477
Formula:
C27H44
Formula Weight:
384.64
Specification
Relative Density:
0.98 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Cholestenone can be used in steroid metabolism research to study the enzymatic conversion of cholesterol by microbial or mammalian pathways.
Library Information
Target:
Endogenous metabolite
Receptor:
Metabolic signaling protein
Pathways:
Metabolism
Plate Number:
AOCL-18
Plate Location:
h10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
2mM DMSO
DMSO Max Solubility:
3.5 mg/mL; 9.1 mM
Ethanol Max Solubility:
2 mg/mL; 5.2 mM
